baber/WOPTO huggingface dataset:
Patent EP-3011447-A1 (EP)
Inventor: GEIMER MATT
IPC: G06F9/445
Filed: 2014-06-05
Abstract: Au lieu qu'une application spécifie qu'elle utilise une API entière, l'application spécifie le ou les sous-ensembles de l'API qu'elle utilise. Des hôtes spécifiques peuvent choisir quand ils souhaitent mettre en œuvre un sous-ensemble de l'ensemble de l'API sans avoir à prendre en charge d'autres sous-ensembles de l'API. Lorsque l'hôte met en œuvre un sous-ensemble de l'ensemble de l'API qui n'était pas pris en charge précédemment, une application qui a spécifié l'utilisation du sous-ensemble nouvellement pris en charge commence à fonctionner sur les hôtes automatiquement. Une application peut spécifier des sous-ensembles ayant différentes versions. Par exemple, les versions de différents sous-ensembles qui sont spécifiés peuvent être différentes. Lorsque l'hôte prend en charge les sous-ensembles utilisés par l'application, l'application est activée (c'est-à-dire, "exécutée"). Lorsque l'hôte ne prend pas en charge un ou plusieurs des sous-ensembles utilisés par l'application, l'application n'est pas activée.
Patent EP-3031209-A1 (EP)
Title: Context-based recommendation system
Inventor: SHAW PHILIP ANTONY
IPC: H04N21/258
Filed: 2014-09-11
Abstract: A content delivery server configured to select from multiple content items a set of content items for display to a user at a user terminal, the content delivery server having access to content identifiers, identifying content items for delivery; a processor operating a content selection program which is arranged to receive the context data for different contexts and to select a set of content items in dependence on the context data, wherein the content items in the set vary with the context data, such that the content of items in a first set for a user in a first context are different from the content of items in a second set for the same user in a second context, and to transmit a recommendation message to the user terminal comprising a set of content identifiers.
Patent EP-3055142-A1 (EP)
Inventor: FRAENKEL BERTRAND
IPC: B60C11/03
Filed: 2014-10-06
Abstract: The invention relates to a tire tread comprising a plurality of blocks (3) made of rubber material, which are formed on both sides of a mid-plane (5) separating said tread (1) into two portions. Each block (3) continuously extends from the mid-plane to the outside of the tread. Each block is defined by two grooves (7, 9) which lead to a first edge (8) of the tread and have a curvature C, and by a third groove (11) which extends from the first groove (7), at the mid-plane (5) of the tread, to a second edge (10) of said tread that is opposite the first edge (8), the second groove (9) leading into said third groove (11).
Patent EP-2986047-A1 (EP)
Inventor: JIANG CHENGGANG
IPC: H04W16/10
Filed: 2014-03-26
Abstract: The present disclosure provides a dynamic spectrum allocation method and a dynamic spectrum allocation device. In the method, a centralized node performs spectrum allocation and transmits a spectrum allocation result to each communication node, so that the communication node operates at a corresponding spectrum resource in accordance with the spectrum allocation result and performs statistics of communication quality measurement information. The centralized node receives the communication quality measurement information reported by the communication node, and determines whether or not it is required to trigger the spectrum re-allocation for the communication node in accordance with the communication quality measurement information about the communication node. When it is required to trigger the spectrum re-allocation, the centralized node re-allocates the spectrum for the communication node.
Patent EP-3044915-A1 (EP)
Inventor: DUNN ANDREW
IPC: H04L12/58
Filed: 2014-09-12
Abstract: L'invention concerne un appareil (1) pour gérer la divulgation de données sensibles durant l'échange de messages. L'appareil est configuré pour être connecté à un réseau de communications, et pour recevoir et transmettre des messages entre des parties (10,11). L'appareil comprend un processeur de données configuré pour déterminer la réception de données sensibles, d'une première partie (10), et pour commander la divulgation de ces données à une seconde partie (11).
Patent EP-3060098-A1 (EP)
Inventor: HEINRICH RALF
IPC: A61B5/00
Filed: 2014-10-20
Abstract: The present invention relates to a method for determining an organ function in a subject, comprising the steps of: providing a first concentration-time curve obtained by transcutaneously measuring in a body fluid at a first position background fluorescence in at least one first time point and fluorescence of an indicator compound in at least a second, a third, a fourth, a fifth, and a sixth time point; providing a second concentration curve obtained by transcutaneously measuring in a body fluid at a second position background fluorescence in at least one seventh time point and fluorescence of an indicator compound in at least a eighth, a ninth, a tenth, an eleventh, and a twelfth time point; fitting the first and the second concentration curve into a kinetic model representing at least four diffusion compartments; and thereby determining an organ function in a subject. The invention further relates to a device for determining an organ function according to the method of the present invention, said device comprising a first sensor for transcutaneously measuring fluorescence of an indicator at a first position, a second sensor for transcutaneously measuring fluorescence of an indicator at a second position; and a data processing unit for fitting the values obtained by the sensors into a kinetic model of one of the preceding claims. The present invention also relates to a kit comprising a device of the present invention and an indicator compound, as well as to a computer or computer network comprising at least one processor, wherein the computer or computer network is adapted to perform the method according to the present invention.
Patent EP-3039377-A1 (EP)
Inventor: COLLE OLIVIER
IPC: G01B11/06
Filed: 2014-08-21
Abstract: The invention concerns a method for determining the position and orientation of at least one diopter consisting of: • illuminating the diopter (6) to be determined using at least one diffuse non-polarised point source of light (1), • acquiring, by means of an image forming device (2), an image (J) for determining polarimetric information of the reflection or reflections of the point source on the diopter to be determined, • locating, in the image (J), any reflection (13, 15) of the point source of light (1) by the diopter (6) to be determined, and, for each located reflection: - calculating the light beam (3) arriving on the image forming device (2) and, as a polarisation parameter, at least the degree of polarisation of same, - calculating the light beam (8) reflected on the diopter (6) to be determined and deducing the position and orientation (5) of the surface element (4) from the light beam (8) reflected on the diopter (6) to be determined, the polarisation parameter of same, and the known position of the point source (1).
Patent EP-3061262-A1 (EP)
Inventor: KAETEL KLAUS
IPC: H04R1/10
Filed: 2014-10-24
Abstract: Une oreillette comprend une membrane (10) montée sur un porte-membrane (12) et prévue entre un espace supérieur (14) et un espace inférieur (16), un actuateur de membrane (18) utilisé pour faire fléchir la membrane (10) en réponse à un signal de commande, et un boîtier (20) contenant le porte-membrane (12), la membrane (10) et l'actuateur de membrane (18). Le boîtier comprend une sortie sonore (22). Le porte-membrane (12) comprend des ouvertures (26a, 26b, 26c), et la membrane (10) comprend des trous (28a, 28b, 28c). Les ouvertures (26a, 26b, 26c) et les trous (28a, 28b, 28c) relient l'espace supérieur (14) et l'espace inférieur (16) l'un à autre. Un gaz peut ainsi circuler par les ouvertures et les trous, entre l'espace supérieur et l'espace inférieur.
Patent EP-2989605-A1 (EP)
Inventor: FERNANDES JORGE M
IPC: H04W12/08
Filed: 2014-02-21
Abstract: This disclosure includes methods and systems for limiting the transfer of funds from an account after a lock feature for the account has been engaged in response to an account lock request. The account lock request can be sent via an SMS message. The lock request can limit the transfer of funds from the account, and generally limit usage of the account for financial transactions. The account can be a funding source for a payment account.
Patent EP-3057650-A1 (EP)
Title: Sampling port
Inventor: DENNIS NICHOLAS
IPC: A61M39/26
Filed: 2014-09-30
Abstract: A sampling port includes a hub having a body that forms a hub chamber for containing a fluid. The hub also has a proximal opening to the hub chamber for receiving a medical implement, and the hub chamber has a valve member that normally closes the opening. The valve member has a valve wall forming a valve interior. The sampling port also has a first and second fluid channel formed by the hub body and in fluid communication with the hub chamber. The first and second channels have radial portions and proximally extending portions with proximally extending longitudinal axes. The proximally extending longitudinal axes form a plane therebetween that diverges from the longitudinal axis of the first fluid channel.
Patent EP-3066059-A1 (EP)
Inventor: FRANKE WOLFRAM
IPC: C01F11/36
Filed: 2014-11-04
Abstract: The invention relates to a setting accelerator for a dry mortar blend, the setting accelerator being in the form of a powder comprising calcium nitrate and having a water content between 0.1% and 20%. The invention furthermore relates to a process for producing such a setting accelerator, wherein either prills and/or granules comprising calcium nitrate and a different nitrate salt are processed forming a powder comprising calcium nitrate and the different nitrate salt and having a water content of higher than 5% and lower than 20%, either an aqueous solution at least comprising dissolved calcium nitrate is spray dried at a temperature between 150°C and 250°C, forming a powder comprising at least calcium nitrate and having a water content between 0.1% and 20%, the powder serving as the setting accelerator. The invention also relates to a dry mortar blend comprising at least a cement, sand and a setting accelerator according to the invention and to a mortar paste comprising the dry mortar blend according to the invention which is mixed with water.
Patent EP-2994597-A1 (EP)
Inventor: HAUGHOM SIGURD KJELL
IPC: F16D3/38
Filed: 2014-04-30
Abstract: A steering -joint device (13) arranged between a string section (11) and a drilling section (12) in a rock-drilling machine (1), the steering joint (13) including a universal- joint cross (131) supported in the string section (11) and the drilling section (12), pivotal around a first and a second pivot axis (1311, 1312), and the universal-joint cross (131) being provided with a first control arm (1313) supported in the string section (11) and a second control arm (1314) supported in the drilling section (12), wherein an end portion (1313a, 1314a) of each of the control arms (1313, 1314) is pivotally arranged in, respectively, a first and a second control-arm bearing (112, 122) in a slanted centre cut-out (115, 125) in an axially displaceable steering sleeve (114, 124), the steering sleeve (114) of the string section (11) having an axial direction which is perpendicular to the pivot axis (1311) of the universal-joint cross (131) through the string section (11) and is slanted relative to the pivot axis (1312) of the universal- joint cross (131) through the drilling section (12), and the steering sleeve (124) of the drilling section (12) having an axial direction which is perpendicular to the pivot axis (1312) of the universal-joint cross (131) through the drilling section (12) and is slanted relative to the pivot axis (1311) of the universal-joint cross (131) through the string section (11).
Patent EP-2996752-A1 (EP)
Inventor: BARLOW ADAM FRANCIS
IPC: A61M16/08
Filed: 2014-05-14
Abstract: A patient interface to provide breathable gas to a patient, comprising: a plenum chamber assembly, comprising: a nasal plenum chamber at least partly defining an upper gas chamber; an oral plenum chamber at least partly defining a lower gas chamber; and a decoupling structure at least partly connecting the nasal plenum chamber and the oral plenum chamber and at least party defining a flow path; a top plate including at least one connection feature configured to releasably retain a first portion of a positioning and stabilising structure; and a faceplate configured to releasably retain a second portion of a positioning and stabilising structure.
Patent EP-3082962-A1 (EP)
Title: Oxidationsfärbemittel mit verringerter haarschädigung
Inventor: WESER GABRIELE
IPC: A61Q5/06
Filed: 2014-11-19
Abstract: Oxidative Färbe- und/oder Aufhellmittel, die als, bevorzugt transparentes, Hydrogel vorliegen und einen pH-Wert im Bereich von 7,0 bis 8,8 aufweisen und die bevorzugt nach Vermischen mit einer sauer eingestellten Oxidationsmittelzubereitung eine Anwendungsmischung mit einem pH-Wert im Bereich von 6,0 bis 7,3 ergeben, ermöglichen eine intensive Färbung bzw. Aufhellung der Fasern bei verringerter Haarschädigung.
Patent EP-2941771-A1 (EP)
Inventor: PAULUS JOUNI
IPC: G10L19/008
Filed: 2014-11-27
Abstract: A decoder for generating an audio output signal comprising one or more audio output channels is provided. The decoder comprises a receiving interface (110) for receiving an audio input signal comprising a plurality of audio object signals, for receiving loudness information on the audio object signals, and for receiving rendering information indicating whether one or more of the audio object signals shall be amplified or attenuated. Moreover, the decoder comprises a signal processor (120) for generating the one or more audio output channels of the audio output signal. The signal processor (120) is configured to determine a loudness compensation value depending on the loudness information and depending on the rendering information. Furthermore, the signal processor (120) is configured to generate the one or more audio output channels of the audio output signal from the audio input signal depending on the rendering information and depending on the loudness compensation value. One or more by-pass audio object signals are employed for generating the audio output signal Moreover, an encoder is provided.
Patent EP-2975675-A1 (EP)
Title: Electrode, method for manufacturing same, and battery using same
Inventor: KIM CHANG HYEON
IPC: H01M10/0525
Filed: 2014-06-09
Abstract: Provided are a non-woven fabric current collector and a method and system of fabricating a battery using the same. An electrode according to an embodiment of the present invention includes a non-woven fabric current collector including a conductive non-woven fabric sheet including a network of conductive fibers and pores for communication between a main surface and the interior thereof; and conductive patterns partially blocking the pores on the main surface of the conductive non-woven fabric sheet.
Patent EP-3066131-A1 (EP)
Inventor: SCHEINBERG DAVID
IPC: A61P35/02
Filed: 2014-11-07
Abstract: The present disclosure relates to an anti-WT-1/HLA/A2 antibody with enhanced antibody dependent cell-mediated cytotoxicity (ADCC) function due to altered Fc glycosylation. The antibody, which has reduced fucose and/or galactose, was compared to its normally glycosylated counterpart in binding assays,  in vitro  ADCC assays, and mesothelioma and leukemia therapeutic models and pharmacokinetic studies in mice. The antibody with normal glycosylation mediated ADCC against hematopoietic and solid tumor cells at concentrations below 1 μg/ml, but the reduced fucosylated antibody was about 5-10 fold more potent  in vitro  against multiple cancer cell lines, was more potent  in vivo  against JMN mesothelioma, and effective against SET2 AML and fresh ALL xenografts. ESKM had a shortened half-life (4.9  vs  6.5 days), but an identical biodistribution pattern in C57BL6/J mice. At therapeutic doses of ESKM, there was no difference in half-life or biodistribution in HLA-A2.1 + transgenic mice compared to the parent strain. Importantly, therapeutic doses of ESKM in these mice caused no depletion of total WBCs or hematopoetic stem cells, or pathologic tissue damage.
Patent EP-3079484-A1 (EP)
Inventor: OLDKNOW CHRIS
IPC: A23D7/005
Filed: 2014-12-11
Abstract: A non-toxic artificial mineral water composition containing bioavailable iron consists of an aqueous solution having a pH of from 1 to 5 containing ferrous ions at a concentration of from 100 to 300 mg/l and a non-toxic amount of at least one metal cation selected from Ca 2+ , Mg 2+ , Zn 2+  and K + , and wherein the composition, when diluted to an iron concentration of 20 μΜ, has an iron uptake, measured as intracellular ferritin, of greater than 120 ng/mg protein. The mineral water composition provides oral, bioavailable iron that has use as a supplement to dietary iron.
Patent EP-3013454-A1 (EP)
Inventor: CLOUD DANIEL M
IPC: B01D46/42
Filed: 2014-06-23
Abstract: Improvements to filtration and vessels such as for filtration and coalescing of gas streams are shown. A filter element with a partial treated region and untreated region such as providing different surface energies or other filtration characteristics are provided. Various keying arrangements for compatibility and /or rotational locking are shown between the filtration vessel, a tubular coalescing baffle, and/or filter element. The tubular coalescing baffle also may include non-louvered pore structure, which provides for more even flow in a two stage type filtration vessel to prevent premature exiting and reduction of flow velocities along the second stage, and/or may additionally or alternatively include drainage apertures such as drain slot formed along a gravitational bottom or otherwise to facilitate additional drainage of coalesced liquid as opposed to letting such liquid be forced through fluid velocity toward the open end of the tubular baffle.
Patent EP-3023021-A1 (EP)
Inventor: CHAE KEUM-OK
IPC: D06F71/18
Filed: 2014-07-15
Abstract: Disclosed is an ironing apparatus for a hat. The ironing apparatus for a hat includes: a hollow spherical conductor having an opening formed at a lower portion thereof; supports installed under the spherical conductor to support the spherical conductor with being spaced apart from a bottom plate; and a hot air supplier installed under the opening formed at the lower portion of the spherical conductor to vertically supply hot air to an inner space of the spherical conductor. According to the present invention, it is possible to rapidly and economically ironing the hat, thereby improving a commercial value of the hat. Further, according to the present invention, it is possible for a user to freely use his/her two hands while adjusting heat required for ironing by using his/her foot during ironing the hat, thereby improving ironing quality of the hat.
Patent EP-3083451-A1 (EP)
Inventor: RIVIERE LUC
IPC: B65D88/78
Filed: 2014-12-19
Abstract: The invention relates to a method for injecting fluid into an underwater facility (100). A fluid-storage system (1) including at least one storage vessel (20-24) with rigid walls containing a functional fluid (30) is lowered to the bottom of the water. At least one portion of the functional fluid is injected into the underwater facility (100). After a time of operation, the fluid-storage system (1), or a portion thereof, including the storage vessel (20-24), is raised back up to the surface.
Patent EP-3031905-A1 (EP)
Inventor: OSAFUNE KENJI
IPC: C12N5/10
Filed: 2014-08-06
Abstract: Provided is a method for inducing pancreatic hormone-producing cells from pancreatic progenitor cells efficiently. The method comprises a step of culturing the cells in a culture medium comprising sodium cromoglicate.
Patent EP-3030261-A1 (EP)
Inventor: WU TZYY-CHOOU
IPC: A61P31/20
Filed: 2014-08-06
Abstract: The present invention provides methods of mucosal tissue administration of therapeutic HPV vaccines, in a prime-boost regimen, which generated antigen-specific CD8+ T cell-mediated immune responses and the expression of tissue-resident memory T cell (Trm) markers on the CD8+ T cells. In some embodiments, the inventive methods employed pNGVL4a-sig/E7(detox)/HSP70 DNA vaccine and TA-HPV in a prime-boost regimen which shows vaccination in the infected mucosal tissues, including those in the cervicovaginal tract, elicited potent antitumor effects and a more effective local immune response in the tissues and regional lymph node, when compared to intramuscular vaccination. Furthermore, targeting the induction of Trm-mediated immune responses can serve as an ideal methodology especially for therapeutic HPV vaccines.
Patent EP-2907858-A1 (EP)
Inventor: OE HIROSHI
IPC: C09J7/29
Filed: 2014-07-09
Abstract: The present invention provides an adhesive tape that ensures sufficient adhesion to a water-repellent surface having a contact angle with pure water of 140 degrees or more even by an instantaneous slapping motion, and that prevents its adhesive from adhering to cutters during processing (cutting, punching, etc.). 
     Specifically, the present invention provides an adhesive tape used for bonding to a water-repellent surface of a packaging material, the water-repellent surface having a contact angle with pure water of 140 degrees or more; 
(1) the adhesive tape comprising a base material layer made of foam, and a natural rubber-based adhesive layer; 
(2) the base material layer having a density of 0.38 g/cm 3  or less and a thickness of 1 mm or less; and 
(3) the natural rubber-based adhesive layer having: 
(i) a weight per unit area of 35 g/m 2  to 65 g/m 2 ; 
(ii) a ball number of 10 or more in a ball tack test specified in JIS Z0237; and 
(iii) a holding power of 100 seconds or more in a holding power test specified in JIS Z0237.
Patent EP-3042664-A1 (EP)
Inventor: NEBOLSIN VLADIMIR EVGENIEVICH
IPC: A61K38/05
Filed: 2014-09-01
Abstract: The invention relates to medicine, in particular, to a method for preventing and/or treating a disease associated with a reduced density of interferon receptors, the method comprising administering an effective amount of glutaryl histamine or a pharmaceutically acceptable salt thereof. Said disease may be hepatitis B, herpes, papilloma virus infection, or multiple sclerosis. The invention also relates to a pharmaceutical composition for prevention and/or treatment of diseases associated with a reduced density of interferon receptors, wherein the composition comprises an effective amount of glutaryl histamine or a pharmaceutically acceptable salt thereof. The invention solves a problem of providing a novel agent effective for overcoming a resistance to interferon therapy in diseases selected from the group including hepatitis B, herpes, papilloma virus infection, or multiple sclerosis.
Patent EP-3054447-A1 (EP)
Inventor: XIAO WEI
IPC: H04L29/06
Filed: 2014-05-05
Abstract: The present invention discloses a voice quality evaluation method and apparatus, where the method includes: determining a first voice quality of a to-be-evaluated voice signal by performing processing and an analysis on the to-be-evaluated voice signal, where the first voice quality includes a quality distortion value and/or a MOS value; and determining a voice quality evaluation result of the to-be-evaluated voice signal according to the first voice quality and at least one key performance indicator KPI parameter of a transmission channel of the to-be-evaluated voice signal. According to the voice quality evaluation method and apparatus in embodiments of the present invention, a voice quality of the to-be-evaluated voice signal is determined by using the to-be-evaluated voice signal and the KPI parameter of the transmission channel of the to-be-evaluated voice signal, which can improve accuracy of voice quality evaluation, thereby further improving user experience.